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Abstract 
Background: 24-hour ambulatory blood pressure and heart rate monitoring  (24hr-ABPM) can 
provide vital information on circadian BP profiles, which are commonly abnormal in 
Parkinson’s disease with and without autonomic failure (PD+AF and PD) and Multiple System 
Atrophy (MSA). 24hr-ABPM has never been directly compared between MSA, PD and 
PD+AF with regards to their cardiovascular autonomic function. We aim to determine the 
usefulness of 24hr-ABPM with diary compared to standard Head-up Tilting (HUT) in 
diagnosing orthostatic hypotension (OH) in these patient groups. 
Methods: 74 patients (23 MSA, 18 PD+AF, 33 PD) underwent cardiovascular autonomic 
screening following by 24hr-ABPM with diary. Standing tests were included during 24hr-
ABPM. The sensitivity and specificity in detecting OH from the 24hr-ABPM standing test was 
compared with HUT. 
Results: During HUT, BP was lower in MSA and PD+AF compared to PD (p<0.01) but there 
was no difference in OH between MSA and PD+AF (p>0.05). MSA and PD+AF had a higher 
proportion of abnormal BP and a reversed BP circadian rhythms compared to those in PD 
(p<0.05) but there was no difference between MSA and PD+AF (p>0.05). All patients were 
divided into those with (OH+) and without OH (OH-) on HUT. Using the standing test during 
24hr-ABPM, a SBP fall of >20 mmHg showed a sensitivity and specificity of 82% and 100 % 
(AUC 0.91, 95% CI 0.84-0.98) in differentiating OH+ from OH-, respectively.  
Conclusions: This study demonstrates that PD+AF and MSA patients, with similar OH during 
HUT, have similar circadian BP patterns. This suggests that autonomic dysfunction influences 
abnormal BP circadian patterns similarly in these 2 disorders. A high sensitivity and specificity 
in detecting OH using 24hr-ABPM supports the use of this technique as an adjunct tool for 
assessing autonomic function in MSA and PD patients. 
Introduction 
24 hour-ambulatory blood pressure and heart rate monitoring (24 hr-ABPM) is widely used in 
patients with blood pressure problems, particularly in those with high blood pressure 
(hypertension). A number of studies have demonstrated the advantage of using this equipment 
to detect and follow-up patients with hypertension (1-3). More recently, 24 hr-ABPM has also 
been utilized as a screening test for autonomic dysfunction patients with orthostatic 
hypotension in conjunction with laboratory tests of autonomic function. Furthermore, 24 hr-
ABPM offers information not only on daytime blood pressure (BP) but also circadian BP 
revealing key information on day- and night-time profiles. In normal subjects, BP is normally 
lower at night-time which has been described as nocturnal blood pressure ‘dipping’. This 
pattern can be absent or reversed (BP night-time>BP daytime) in patients with autonomic 
failure, such as Multiple System Atrophy. These patients tend to have lower BP during the day 
(due to the repeated bouts of OH) and a loss of BP dipping or even a higher BP at night, also 
influenced by supine hypertension, a common occurrence in autonomic failure (4). According 
to the latest guidelines from the European Society of Hypertension and the European Society 
of Cardiology for the management of hypertension, those who have a normal BP reduction at 
night (BP decrease >10%) are classified as dippers while those with a nocturnal fall of <10% 
BP are classified as non-dippers. Those patients with a BP increase during the night are grouped 
as reverse dippers, which are more likely to occur in autonomic failure (5). 
24 hr-ABPM is commonly reported as abnormal in patients with Parkinson’s Disease (PD) 
regardless of their underlying autonomic function (6). The prevalence of non-dippers in PD 
ranges from 48 to 95% (6-8).  Abnormal nocturnal circadian falls in blood pressure occur more 
often in PD+AF compared to PD suggesting that there is a link between abnormal BP circadian 
rhythms and orthostatic hypotension (8). More recently, 24 hr-ABPM was used among 
different forms of parkinsonian disorders, including Multiple system atrophy (MSA) and 
Progressive supranuclear palsy (PSP) (ref). The results showed that a number of these patients 
had a significantly higher proportion of absent nocturnal BP dipping compared to age-matched 
controls. These findings support the use of 24-hr ABPM for screening autonomic function 
when the autonomic laboratory is not available (6). Nevertheless, 24 hr-ABPM has never been 
specifically compared in PD patients with and without autonomic failure and MSA patients 
with autonomic failure. Furthermore, the efficacy of 24 hr-ABPM with an autonomic protocol 
diary in detecting OH, compared with laboratory head-up tilt-table testing in these patient 
groups, has also never been evaluated. Such information would help with the often difficult 
task of differentiating MSA and PD+AF and with the screening of autonomic function in the 
community setting. The aim of this study was, therefore, to 1) examine 24 hr-ABPM in patients 
with MSA, PD+AF and PD and 2) determine the usefulness of 24 hr-ABPM compared to 
standard orthostatic challenge testing (10 minute Head-up Tilt) in diagnosing orthostatic 
hypotension (OH) in these patients.  
 
Methods 
Participants 
All patients were recruited from the Autonomic Unit, National Hospital for Neurology and 
Neurosurgery (NHNN), Queen Square, London, UK between 2004 and 2013. Idiopathic PD 
(without autonomic failure) patients were diagnosed using the UK Parkinson’s Disease Society 
Brain Bank diagnostic criteria [UK-PDSBB]. PD with autonomic failure (PD+AF) was defined 
as idiopathic PD with orthostatic hypotension (Systolic/Diastolic blood pressure fall > 20/10 
mmHg) (9, 10). MSA patients were diagnosed using Gilman’s criteria (11) for probable MSA. 
Only probable MSA patients with orthostatic hypotension were included in the study. 
All patients had a good and sustainable response to levodopa treatment without features 
suggesting atypical parkinsonian disorders. Participants had no previous history of 
cardiovascular disease (e.g. coronary heart disease, heart failure, cardiac arrhythmia, and 
hypertension), Diabetes mellitus or other illnesses that could affect autonomic function. PD 
patients were asked to stop dopaminergic medications and other drugs that could interfere with 
autonomic function at least 12 hours before autonomic testing. 
Patients were selected only if cardiovascular autonomic screening tests (AFT) and 24 hr-
ABPM were performed during the same admission. In order to verify the efficacy of 24 hr-
ABPM in detecting OH using an autonomic diary protocol, only patients who completed a 
diary as part of the test were included in the sensitivity analyses.  
Clinical history and evaluation of autonomic nervous system function 
Demographic data, such as age at testing, dopaminergic medications and disease duration were 
also noted. 
Cardiovascular autonomic screening tests (AFT) 
All patients underwent screening autonomic function tests (AFT) using the Autonomic Unit 
Queen Square protocols (12) to ascertain whether or not patients had orthostatic hypotension 
(OH) and autonomic failure (AF). More info needed here on HUT etc. 
24 hour-Ambulatory Blood Pressure and Heart Rate Monitoring (24 hr-ABPM) 
All patients were fitted with the 24 hr-ABPM (model 90207, Spacelabs™ Medical, Redmond, 
Washington) after their AFT as part of their autonomic investigations. BP and HR were 
recorded every 20 minutes during the day (0800-2300) and every 60 minutes during the night 
(2300-0800). The average BP and HR were calculated for daytime, night-time and the entire 
24-hour period. Patients were asked to record their symptoms in the diary during the day (e.g. 
dizziness, light-headedness, blurred vision etc) as well as the position and activity (lying down, 
sitting, standing, walking, and exercising) at the same time. Patients were also asked to record 
additional BP readings in addition to the automated readings if they developed symptoms. Bed- 
and wake-up time were also recorded in order to determine the period of sleep. Postural 
challenges were included in the diary for patients to complete during the 24 hr-ABPM 
monitoring. These included an orthostatic challenge using a 5-minute standing test. Patients 
were asked to press a recording button after 5-minute of lying down and again after 5-minute 
standing 4 times throughout the 24 hours (when?). Symptoms (if experienced by patients) were 
also noted in the diary. BP and HR variability were derived from the standard deviations of the 
means of the specific period of times (24-hr, daytime and night-time). 
Patients were classified into 3 groups: dipper (BP fall during night-time>10% compared to 
daytime), absent nocturnal BP fall or non-dipper (BP fall during night-time<10% compared to 
daytime) and reverse nocturnal BP (BP higher during night-time than daytime). Patients with 
an average daytime SBP >140 mmHg or DBP >90 were defined as daytime hypertensives and 
those with nighttime SBP >125 or DBP >75 as nighttime hypertensives according to 
international guidelines (13).  
Statistical Analyses 
Data are presented as mean (± 1 SD) or median (inter-quartile range), where appropriate. 
Analysis of covariance (ANCOVA) was used for comparisons between the 3 groups for 
normally distributed data while the Kruskal-Wallis test was used if data were non-normally 
distributed. If there was a significant difference, Mann-Whitney U tests were then used to 
compare between 2 groups for non-normally distributed data and unpaired t-tests for normally 
distributed data with Bonferroni corrections. Chi-square analyses were used for analysis of 
categorical variables.  
SBP and DBP responses from the 24 hr-ABPM standing test with the greatest degree of BP 
reduction were compared with the BP and HR responses during HUT using a standard criteria 
of OH (SBP fall >20 mmHg or DBP fall >10 mmHg). Considering the BP responses during 
HUT as a gold standard test, sensitivity (Sn) of the 24 hr-ABPM to detect OH was defined as 
the proportion of patients who met the criteria of OH from a standing test during 24 Hr 
monitoring and the proportion of patients who met the criteria of OH during laboratory HUT. 
Specificity (Sp) was defined as the proportion of patients who did not meet the criteria of OH 
in the standing test in 24 Hr monitoring and all patients who were correctly classified as not 
having OH from HUT. ROC (Receiver operating characteristic) analysis was used to evaluate 
the sensitivity and specificity in detecting OH from 24 hr-ABPM and to calculate Sn and Sp 
using different BP cut-off points. In general, the optimal cut-off point would be both Sn and 
Sp as close to 100% as possible. Nonetheless, it is less likely to happen as the Sn tends to vary 
inversely with Sp (Sn increases as Sp decreases, or vice versa). In this study, ROC curves were 
plotted as Sn against 1-Sp and were used to determine the Sn and Sp of the 24 hr-ABPM in 
detecting a fall of 20-mmHg SBP and 10-mmHg DBP (according to the standard OH diagnostic 
criteria).  
The area under the curve (AUC) of the 24 hr BP profile was also calculated (how?). The AUC 
is an overall summary of the diagnostic performance of a test. The perfect discrimination for 
AUC is 1, which means the diagnostic test can perfectly differentiate between two conditions 
with both Sn and Sp equalling 100%. An AUC of 0.9 or higher represents an outstanding 
discrimination. A value of 0.8-0.9 shows excellent discrimination and a value of 0.7-0.8,  
acceptable discrimination. An AUC of 0.5 or less indicates that the diagnostic accuracy is 
questionable and not different from random chance.  Statistical analyses were carried out using 
STATA 11.0 (STATA Corporation, College station, Texas, USA). All tests were 2-sided and 
a p value of <0.05 was considered significant. 
Results 
Demographic data 
74 patients (23 MSA, 18 PD+AF, 33 PD) were included in the analyses. Patients with PD+AF 
were significantly older than PD and MSA (both p<0.01) but there was no difference in age 
between MSA and PD (p=0.55). There was no difference in disease duration among groups 
(p=0.23). Dopaminergic treatment was more commonly used in patients with PD and PD+AF 
compared to those with MSA (MSA vs. PD+AF; p=0.01 and MSA vs. PD; p<0.01). There was 
no difference in the number of patients on dopaminergic medication among PD and PD+AF 
(p=0.53, Table 1).    
Table 1. Patient demographic data  
Variable MSA PD+AF PD 
Number 23 18 33 
% Male 48 44 67 
Age at testing;  Mean (SD), yrs 62+9 72+7*$ 64+10 
Disease duration;  Median (IQR), yrs 4 (3-6) 7 (4-10) 6 (2-10) 
% Dopaminergic treatment 39*# 78 85 
Values are mean+SD unless stated, * p<0.05 vs. PD, # p<0.05 vs. PD+AF, $p<0.05 vs. MSA 
 
Cardiovascular responses to HUT  
Supine SBP and DBP were not significantly different between MSA, PD+AF, PD patients but 
there was a higher baseline HR in MSA patients. During head-up tilting (HUT), SBP was 
significantly lower in patients with MSA and PD+AF compared to PD (p<0.01). 
Correspondingly, BP changes during HUT were significantly higher in MSA and PD+AF when 
compared to PD. There were no difference in SBP and DBP during HUT between MSA and 
PD+AF (p=0.35 and p=0.90, respectively) but HR was significantly higher in MSA during 
HUT (Table 2). During HUT, all patients with MSA and PD+AF fulfilled the criteria of OH, 
whereas none of the PD patients met the criteria of OH during HUT.   
Table 2. Blood pressure and HR during supine and head-up tilting and orthostatic 
changes in MSA, PD+AF and PD patients 
Variable MSA (n=17) PD+AF (n=11) PD (n=16) 
HUT    
  Supine SBP 137+18 140+21 130+14 
  Supine DBP 81+11 75+15 75+10 
  Supine HR 77+9 69+4$ 69+10$ 
  Tilt SBP 95+19* 101+24* 126+16 
  Tilt DBP  60+13* 63+17* 76+10 
  Tilt HR 85+13 77+6$ 76+11$ 
  Orthostatic ∆SBP  -42+17* -39+17* -5+8 
  Orthostatic ∆DBP -20+12* -12+10* 0+5 
  Orthostatic ∆HR 8+6 8+5 7+5 
Values are mean+SD unless stated, *p<0.05 vs. PD, $p<0.05 vs. MSA 
 
24 hour-Ambulatory BP Monitoring data 
MSA patients had significantly lower daytime SBP and DBP compared to PD patients (both 
p<0.01), whereas there was no difference between PD+AF and PD patients (p=0.34), as well 
as between MSA and PD+AF (p=0.17). Daytime average HR was not different among patient 
groups (p=0.28). During nighttime, there was a significantly higher SBP in PD+AF patients 
compared to PD (p=0.01), but no difference between MSA and PD (p=0.17) or MSA and 
PD+AF (p=0.11). Nighttime HR in MSA was greater than PD (p=0.03) but there was no 
difference between PD and PD+AF (p=0.06). The average SBP, DBP and HR in the 24-hour 
period were not different among groups (p>0.05).  
There were no differences in the number of patients with daytime and nighttime hypertension 
among groups (p>0.05). The sizes of the nocturnal blood pressure change in SBP and DBP 
were significantly lower in MSA compared to PD (both p<0.01) but there was no difference 
between MSA and PD+AF (SBP; p=0.71 and DBP; p=0.55). The size of the nocturnal HR fall 
was not different among patient groups (p=0.06). Correspondingly, MSA and PD+AF had a 
higher proportion of patients with abnormal BP circadian rhythms (both absent and reversed 
BP circadian rhythms; non-dippers) than patients with PD (p<0.01 and p=0.04, respectively) 
but not between MSA and PD+AF (p=0.08). Patients with reversed BP circadian rhythms were 
significantly more common in MSA and PD+AF compared to those with PD (both p<0.01) but 
not between MSA and PD+AF (p=0.14). There was also no difference in the number of patients 
with an absent BP circadian rhythm among groups (p>0.05; Table 3). 
 
 
 
 
 
 
  
Table 3. 24 hr-ABPM profiles in MSA, PD and PD+AF 
Variable MSA (n=23) PD+AF (n=18) PD (n=33) 
Daytime 
- Mean SBP 
- Mean DBP 
- Mean HR 
 
116+12* 
71+7* 
81+9 
 
122+13 
73+12 
75+7 
 
127+12 
77+9 
79+10 
Patients with daytime 
hypertension, % (n) 
4% (1/23) 6% (1/18) 18% (6/33) 
Nighttime 
- Mean SBP 
- Mean DBP 
- Mean HR 
 
119+12 
70+9 
72+11* 
 
127+16* 
72+13 
65+8 
 
115+12 
67+9 
66+8 
Patients with nighttime 
hypertension, % (n) 
30% (7/23) 50% (9/18) 24% (8/33) 
24-hour values 
- Mean SBP  
- Mean DBP 
- Mean HR 
 
117+11 
71+6 
80+9 
 
123+13 
72+11 
73+7 
 
125+11 
76+9 
76+9 
Patients with abnormal BP 
circadian rhythm, % (n) 
96% (22/23)* 78%(14/18)* 48% (16/33) 
Patients with absent BP 
circadian rhythm, % (n) 
39% (9/23) 22%(4/18) 33% (11/33) 
Patients with reversed BP 
circadian rhythm, % (n) 
57% (13/23)* 56%(10/18)* 15% (5/33) 
Mean Nocturnal BP/HR change 
- SBP (%) 
- DBP (%) 
- HR (%) 
 
+2.8 +9.0* 
-1.6 +10.8* 
-11.1+9.9 
 
+4.3 +14.7* 
-0.1 +20.7* 
-12.7+5.7 
 
-9.1 +8.9 
-12.9 +11.0 
-16.1+7.3 
Values are mean+SD unless stated, * p<0.05 vs. PD, # p<0.05 vs. PD+AF, $p<0.05 vs. MSA 
 
24-hr SBP variability was significantly higher in MSA and PD+AF patients compared to PD 
(both p<0.01) but there was no difference in 24-hr DBP variability between MSA and PD+AF 
(p=0.32). There was a significantly lower daytime DBP variability in PD+AF compared to PD.  
MSA patients had significantly lower 24-hr HR variability compared to PD (p<0.01). SBP, 
DBP and HR variability during nighttime were not different among groups (p>0.05; Table 4).  
 
 
Table 4. 24 hr-ABPM BP and HR variability in MSA, PD and PD+AF 
Variable MSA (n=23) PD+AF (n=18) PD (n=33) 
BP variability 
Daytime 
- SBP  
- DBP  
- HR  
 
Nighttime 
- SBP  
- DBP  
- HR  
 
24-hr 
- SBP 
- DBP 
- HR  
 
 
15.6+5.2* 
10.0+2.9 
6.7+2.7* 
 
 
11.2+6.4 
7.9+3.6 
4.4+2.2 
 
 
15.5+4.5* 
10.2+2.3 
7.5+2.8* 
 
 
16.8+4.9* 
10.8+2.8* 
7.8+2.9 
 
 
12.8+5.3 
7.8+3.1 
5.5+2.7 
 
 
17.2+4.5* 
11.2+2.7 
8.4+2.6 
 
 
11.6+4.4 
8.9+2.6 
9.3+3.2 
 
 
9.5+4.1 
7.3+3.0 
4.8+2.4 
 
 
13.1+4.6 
9.9+3.0 
10.2+2.9 
Values are mean+SD, * p<0.05 vs. PD, # p<0.05 vs. PD+AF, $p<0.05 vs. MSA 
SBP=Systolic Blood Pressure, DBP=Diastolic Blood Pressure; values in mmHg, Heart 
Rate=HR; value in bpm. 
 
 
24 hr-ABPM and patient-report diary  
Out of 74, 44 (59%) patients completed the diary during the 24 hr-ABPM monitoring. There 
was no difference in the number of patients who completed the diary among groups; 17(74%) 
MSA, 11(61%) PD+AF and 16 (48%) PD patients. For the purpose of the sensitivity and 
specificity analyses of 24 hr-ABPM in detecting OH, patients were divided into those with and 
those without OH according to the BP responses during HUT. MSA and PD+AF patients were 
combined as a single group (OH+ group) and PD patients were a control group (OH-). The 
average supine SBP was significantly higher in patients with OH (OH+), but the mean DBP 
and HR were not different compared to patients without OH (OH-). During head-up tilting 
(HUT), SBP was significantly lower in OH+ compared to OH- (p<0.01). By definition, the 
degree of SBP and DBP changes during HUT were significantly higher in OH+ compared with 
OH- (p<0.01).  
Cardiovascular responses to HUT and standing test using ABPM 
With 24 hr-ABPM, supine SBP, DBP and HR were not different between OH+ and OH- but 
the average SBP and DBP were significantly lower in OH+ during the standing test compared 
to OH-. The degree of orthostatic changes (both SBP and DBP) were also significantly different 
between OH+ and OH- (p<0.05) but not for HR (Table 5). Was OH lower during the stand 
test? 
Table 5. Blood pressure and HR during supine, head-up tilting and orthostatic changes 
in patients without OH (PD) compared with patients with OH (MSA and PD+AF) 
Variable 
Patients with OH 
(MSA and PD+AF) 
Patients without OH 
(PD) 
Number of patients 28 16 
HUT 
  
  Supine SBP  138+16£ 127+13 
  Supine DBP 79+11 74+9 
  Supine HR 73+8 70+7 
  Tilt SBP  100+19ϕ£ 125+17 
  Tilt DBP 63+13ϕ£ 75+8 
  Tilt HR 81+12ϕ 78+9 
  ∆SBP  -38+15£ -3+9 
  ∆DBP -16+11£ 1+5 
  ∆HR 8+6 8+4 
Standing test  
   Supine SBP 
   Supine DBP 
   Supine HR 
   Stand SBP 
   Stand DBP 
   Stand HR 
   ∆SBP  
   ∆DBP  
   ∆HR 
 
128+16 
75+13 
74+11 
99+14ϕ£ 
62+11ϕ£ 
84+12ϕ 
-29+19£ 
-13+13£ 
10+7 
 
128+18 
74+11 
74+10 
122+16 
78+12 
81+11 
-6+6 
4+6 
7+5 
Values are mean+SD, £ p<0.01 vs. patients without OH, ϕp<0.01 vs. corresponding Supine 
 
  
ROC analysis for detecting OH during HUT and standing tests using ABPM with autonomic 
protocol diary. 
Using 24 hr-ABPM, the area under the curve (AUC) that distinguishes OH+ from OH- was 
0.87 (95% CI, 0.75-0.99). A fall of 20 mmHg or more in SBP showed a sensitivity and 
specificity of 82% and 100% (AUC 0.91, 95% CI 0.84-0.98) in differentiating OH+ from OH-
, respectively. A DBP fall of 10 mmHg or more had a 57% sensitivity and a 94% specificity to 
discriminate OH+ from OH- with an AUC of 0.75 (0.64-0.87; Table 6). A 20 mmHg systolic 
BP fall criteria had a significantly higher efficacy in detecting OH compared to a 10-mmHg 
DBP fall using the 24 hr-ABPM with the autonomic protocol diary (p<0.01). 
Table 6. Sensitivity analysis for 24 hr-ABPM in detecting orthostatic hypotension (OH)  
 
 
Sensitivity (%) 
 
Specificity (%) 
 
AUC 
(95% CI) 
BP 
- SBP fall > 20 mmHg 
- DBP fall > 10 mmHg 
 
 
 
82 
57 
 
 
100 
94 
 
 
0.91 (0.84-0.98) 
0.75 (0.64-0.87) 
 
  
Discussion 
The aim of this study was to 1) examine 24 hr-ABPM in patients with chronic autonomic failure 
(MSA+AF, PD+AF and PD) and 2) determine the effectiveness of 24 hr- ABPM compared to 
standard orthostatic challenge testing (10 minute Head-up Tilt) in diagnosing orthostatic 
hypotension (OH) in these patients. The main findings in this study were that an abnormal 
circadian BP rhythm (either a blunted nocturnal fall of BP or a reversed nocturnal fall) occurred 
in about half of the patients with PD. This proportion was higher in PD+AF and in patients 
with MSA. In comparison to a recent study (6), the prevalence of an abnormal circadian BP 
rhythm in PD in the present study was similar whereas the prevalence of an abnormal circadian 
BP rhythm in MSA patients in the present study was higher (68% vs. 96%, respectively). These 
inconsistent MSA results may be explained by the fact that this study categorized patients with 
regards to a patient’s diagnosis and their autonomic function, whereas the previous study used 
only a diagnostic category (e.g., MSA patients without autonomic failure were included). 
Furthermore, a reversed nocturnal circadian BP pattern was more common in autonomic failure 
patients, presenting in more than 50% of MSA and PD+AF patients compared to only 15% in 
PD patients. These findings suggest that even though a blunted nocturnal fall in 24-hr BP 
profiles can often be seen among PD patients without autonomic failure, a reversed nocturnal 
circadian BP pattern is much more common in patients with autonomic failure (PD+AF and 
MSA). Daytime SBP variability was also higher in patients with autonomic failure, which 
could be due to greater fluctuations in BP in MSA and PD+AF during daily activities compared 
to patients without autonomic failure, and supports the idea that this value could also be an 
additional useful measurement in 24 hr-ABPM in patients with suspected autonomic failure 
and/or orthostatic hypotension. The 24-hr BP profiles in patients with MSA and PD+AF were 
relatively similar suggesting that 24 hr-ABPM patterns cannot be used to discriminate between 
MSA and PD+AF.  
 Human circadian rhythms are controlled by the suprachiasmatic nucleus (SCN) in the 
hypothalamus (14). The SCN projects afferent input to the paraventricular nucleus (PVN), 
which plays an important role in controlling various autonomic functions, such as stress 
responses and metabolism (15). Both sleep and physical activity have a large influence on BP 
and HR circadian changes, including the normal physiological blood pressure fall during sleep 
(16). Although the cause of abnormal circadian BP rhythms in PD and MSA remains unclear, 
the involvement of SCN and PVN are likely to play an important contributing role (17). An 
abnormal circadian BP rhythm in MSA is supported by prior pathological studies showing 
pathological changes within both the paraventricular nucleus (18) and the suprachiasmatic 
nucleus (19) in MSA. In contrast to MSA, the neuronal loss and pathological involvement in 
these structures have never been reported in PD and PD+AF. Nevertheless, sleep dysfunction 
is common in both patients with PD and MSA. The major cause of this problem includes REM 
(Rapid Eye Movement) sleep behavior disorder (RBD), obstructive sleep apnea (OSA) and 
excessive daytime somnolence (EDS). These features may partly explain the reason why 
abnormal circadian BP profiles frequently occur in both disorders. Although abnormal 
circadian BP rhythms are common in PD, PD+AF and MSA, it is important to note that the 
number of patients with a reversed circadian BP profile at night was significantly higher in 
PD+AF and MSA compared to PD (without AF). This finding suggests that autonomic 
dysfunction plays an important contributing role in the control of circadian BP rhythms. Supine 
hypertension is a common feature in patients with autonomic failure (20) and is also associated 
with OH (e.g., the severity of autonomic failure) (4). It is thus very likely that supine 
hypertension contributed to the reversed circadian BP pattern in MSA and PD+AF patients in 
the present study. The cause of supine hypertension in MSA has been suggested to result from 
an inappropriate residual sympathetic tone (21). These findings also emphasize that the 
reversed circadian BP pattern from 24 hr-ABPM is a shared phenomenon in both patients with 
autonomic failure from both pre- (MSA) and post-ganglionic (PD) lesions, rather than a 
disease-specific feature. 
 
The present study also showed that using an autonomic protocol diary alongside 24 hr-ABPM 
is useful for helping diagnose patients with OH. Using the standard criteria of OH, this 
technique provides a reasonably high sensitivity (82%) and specificity (100%) to distinguish 
OH+ from OH- patients with parkinsonism. Nevertheless, a 20-mmHg fall of SBP has a 
significantly better efficacy in detecting OH from 24 hr-ABPM when compared with a 10-
mmHg fall of DBP. To date, there has been no study that has used a diary with 24 hr- ABPM 
to investigate patients with OH. Given that these are non-invasive, relatively simple tests to 
perform without a requirement of an autonomic laboratory, this technique should be included 
as part of autonomic investigations in suspected OH workups. An adjunct diary to 24 Hr BP 
monitoring can also provide additional information with regards to the effect of patient 
activities on BP and HR and their relation to symptoms. Such an approach would allow the 
clinician/scientist to make a connection between activities and BP/HR during events if 
symptoms develop (22).  24 hr-ABPM can also be used to monitor BP and HR in patients with 
OH/autonomic failure after starting anti-hypotensive medications. 
 
In conclusion, this study demonstrated that patients with PD+AF and MSA, who had a similar 
degree of orthostatic hypotension during HUT, generally have similar circadian BP and HR 
patterns as revealed by 24 hr-ABPM. As abnormal circadian rhythms are similarly present in 
PD+AF and MSA, this suggests that the proportion of abnormal BP circadian patterns (both 
absent and reversed BP circadian rhythm) in 24 hr-ABPM depends on the autonomic function 
rather than the diagnosis. Moreover, this study also, for the first time demonstrated that 24 hr-
ABPM can offer more information regarding OH in patients with autonomic failure if a patient-
completed autonomic protocol diary containing postural challenges (standing) are used. This 
approach has reasonably high sensitivity and specificity in detecting OH.  
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